Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study (Q28283021)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study
scientific article

    Statements

    title
    Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study (English)
    0 references
    author name string
    I Schreiber
    series ordinal
    1
    0 references
    M Buchfelder
    series ordinal
    2
    0 references
    M Droste
    series ordinal
    3
    0 references
    K Forssmann
    series ordinal
    4
    0 references
    K Mann
    series ordinal
    5
    0 references
    B Saller
    series ordinal
    6
    0 references
    C J Strasburger
    series ordinal
    7
    0 references
    publication date
    January 2007
    0 references
    volume
    156
    0 references
    issue
    1
    0 references
    page(s)
    75-82
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q28283021&oldid=986692822"